Generation of locus-specific probes for interphase fluorescence in situ hybridisation - Application in Barrett's esophagus

Experimental and Molecular Pathology

Volumn 77, Issue 1, 2004, Pages 26-33

  Doak, S H ^a   Saidely, D ^a   Jenkins, G J S ^a   Parry, E M ^a   Griffiths, A P ^b   Baxter, J N ^b   Parry, J M ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Barrett's esophagus; DNMT1; DNMT3a; Fluorescence in situ hybridisation; Locus specific probes

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CENTROMERE; CHROMOSOME 4; CHROMOSOME NOR; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; FLUORESCENCE ANALYSIS; GENE AMPLIFICATION; GENE LOCUS; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; METHYLATION; PLOIDY; STATISTICAL SIGNIFICANCE; TECHNIQUE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CHROMOSOMES, HUMAN, PAIR 4; DNA MODIFICATION METHYLASES; DNA PROBES; ESOPHAGEAL NEOPLASMS; FEMALE; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED;

EID: 3042600728     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2004.04.001     Document Type: Article

References (29)

1. Ahluwalia A., Hurteau J.A., Bigsby R.M., Nephew K.P. DNA methylation in ovarian cancer: II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells. Gynecol. Oncol. 82:2001;299-304
2. Antoun G., Baylin S.B., Ali-Osman F. DNA methyltransferase levels in altered CpG methylation in the total genome and in the GSTP1 gene in human glioma cells transfected with sense and antisense DNA methyltransferase cDNA. J. Cell. Biochem. 77:2000;372-381
3. Bian Y.S., Osterheld M.C., Fontolliet C., Bosman F.T., Benhattar J. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterology. 122:2002;1113-1121
4. Croft J., Parry E.M., Jenkins G.J.S., et al. Analysis of the premalignant stages of Barrett's esophagus through to adenocarcinoma by comparative genomic hybridisation. Eur. J. Gastroenterol. Hepatol. 14:2002;1179-1186
5. Doak S.H., Jenkins G.J.S., Parry E.M., D'Souza F.R., Griffiths A.P., Toffazal N., Shah V., Baxter J.N., Parry J.M. Chromosome 4 hyperploidy represents an early genetic aberration in pre-malignant Barrett's esophagus. Gut. 52:2003;623-629
6. De Both N.J., Wijnhoven B.P.L., Sleddens H.F.B.M., Tilanus H.W., Dinjens W.N.M. Establishment of cell lines from adenocarcinomas of the esophagus and gastric cardia growing in vivo and in vitro. Virchows Arch. - An International Journal of Pathology. 438:2001;451-456
7. De Marzo A.M., Marchi V.L., Yang E.S., Veeraswamy R., Lin X.H., Nelson W.G. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 59:1999;3855-3860
8. Eads C.A., Lord R.V., Kurumboor S.K., Wickramasinghe K., Skinner M.L., Long T.I., Peters J.H., DeMeester T.R., Danenberg K.D., Danenberg P.V., Laird P.W., Skinner K.A. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res. 60:2000;5021-5026
9. Eads C.A., Lord R.V., Wickramasinghe K., Long T.I., Kurumboor S.K., Bernstein L., Peters J.H., DeMeester S.R., DeMeester T.R., Skinner K.A., Laird P.W. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 61:2001;3410-3418
10. Eastmond D.A., Schuler M., Rupa D.S. Advantages and limitations of using fluorescence in situ hybridisation for the detection of aneuploidy in interphase human cells. Mutat. Res. 348:1995;153-162
11. El-Deiry W.S., Nelkin B.D., Celano P., Chiu Yen R.W., Falco J.P., Hamilton S.R., Baylin S.B. High expression of the DNA methyltransferase gene characterises human neoplastic cells and progression stages of colon cancer. Proc. Natl. Acad. Sci. 88:1991;3470-3474
12. Jubb A.M., Bell S.M., Quirke P. Methylation and colorectal cancer. J. Pathol. 195:2001;111-134
13. Khan S.M., Pillay S.P., Papadimos D., Yong J.W.K., Roberts H.J.V., Crawford D.H. Barrett's esophagus: a technique for the culture of Barrett's esophageal cells. J. Gastroenterol. Hepatol. 12:1997;606-611
14. Klump B., Hsieh C.-J., Holzmann K., Gregor M., Porschen R. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. Gastroenterology. 115:1998;1381-1386
15. Mizuno S., Chijiwa T., Okamura T., Akashi K., Fukumaki Y., Niho Y., Sasaki H. Expression of DNA methyltransferases DNMT1, 3A and 3B in normal hematopoiesis and in acute and chronic myelogenous leukaemia. Blood. 97:2001;1172-1179
16. Okano M., Xie S., Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19:1998;219-220
17. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases DNMT3a and DNMT3b are essential for de novo methylation and mammalian development. Cell. 99:1999;247-257
18. Palanca-Wessels M.C., Barrett M.T., Galipeau P.C., Rohrer K.L., Reid B.J., Rabinovitch P.S. Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology. 114:1998;295-304
19. Popescu N.C., Zimonjic D.B. Molecular cytogenetic characterisation of cancer cell alterations. Cancer Genet. Cytogenet. 93:1997;10-21
20. Riegman P.H.J., Vissers K.J., Alers J.C., Geelen E., Hop W.C.J., Tilanus H.W., Van Dekken H. Genomic alterations in malignant transformation of Barrett's esophagus. Cancer Res. 61:2001;3164-3170
21. Rockett J.C., Larkin K., Darnton S.J., Morris A.G., Matthews H.R. Five newly established esophageal carcinoma cell lines: phenotypic and immunological characterization. Br. J. Cancer. 75:1997;258-263
22. Saito Y., Kanai Y., Nakagawa T., Sakamoto M., Saito H., Ishi H., Hirohashi S. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int. J. Cancer. 105:2003;527-532
23. Van Dekken H., Vissers C.J., Tilanus H.W., Tanke H.J., Rosenberg C. Clonal analysis of a case of multifocal esophageal (Barrett's) adenocarcinoma by comparative genome hybridisation. J. Pathol. 188:1999;263-266
24. Varella-Garcia M., Gemmill R.M., Rabenhorst S.H., Lotto A., Drabkin H.A., Archer P.A., Franklin W.A. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma. Cancer Res. 58:1998;4701-4707
25. Varis A., Puolakkainen P., Savolainen H., Kokkola A., Salo J., Nieminen O., Nordling S., Knuutila S. DNA copy number profiling in esophageal Barrett's adenocarcinoma: comparison with gastric carcinoma and esophageal squamous cell carcinoma. Cancer Genet. Cytogenet. 127:2001;53-58
26. Vertino P.M., Yen R.W.C., Gao J., Baylin S.B. De novo methylation of CpG island sequences in human fibroblasts over-expressing DNA (cytosine-5) methyltransferase. Mol. Cell. Biol. 16:1996;4555-4565
27. von Bergh A., Emanuel B., van Zelderen-Bhola S., Smetsers T., van Soest R., Stul M., Vranckx H., Schuuring E., Hagemeijer A., Kluin A DNA probe combination for improved detection of MLL/1 1q23 breakpoints by double-color interphase-FISH in acute leukemias. Genes Chromosomes Cancer. 28:2000;14-22
28. Walch A.K., Zitzelsberger H.F., Bruch J., Keller G., Angermeier D., Aubele M.M., Mueller J., Stein H., Braselmann H., Siewert J.R., Hofler H., Werner M. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am. J. Pathol. 156:2000;555-566
29. Werner M., Ludwig W., Aubele M., Nolte M., Zitzelsberger H., Komminoth P. Interphase cytogenetics in pathology: principles, methods and applications of fluorescence in situ hybridisation (FISH). Histochem. Cell Biol. 108:1997;381-390